Browse Items · NEOMED Bibliography Database

Biochemical Disease-free Survival Rates Following Definitive Low-dose-rate Prostate Brachytherapy With Dose Escalation To Biologic Target Volumes Identified With Spect/ct Capromab Pendetide

Rectal Morbidity After Permanent Prostate Brachytherapy With Dose Escalation To Biologic Target Volumes Identified By Spect/ct Fusion

Single Photon Emission Computerized Tomography With Capromab Pendetide Plus Computerized Tomography Image Set Co-registration Independently Predicts Biochemical Failure

Stereotactic Radiosurgeny For Renal Cancer: Phase I Safety And Toxicity

Tags: 2012, Brindle J, Ellis R J, International Journal of Radiation Oncology Biology Physics, Kaminsky D A, Kudithipudi V, Kunos C, Nuclear Medicine & Medical Imaging, oncology, Patel R B, Ponsky L, Radiology, Zhang Y

Long-term Outcomes Following Igrt For Localized Prostate Cancer: Dose Escalation To Spect/ct Determined Biologic Target Volumes And The Bdfs Predictive Value Of Capromab Pendetide

Tags: 2009, Bodner D, Brelin A, Ellis R J, Faulhaber P F, Fu P, International Journal of Radiation Oncology Biology Physics, Kaminsky D A, Nuclear Medicine & Medical Imaging, oncology, Radiology, Zhou E H

Use Of In-111-capromab Pendetide Immunoscintigraphy To Image Localized Prostate Cancer Foci Within The Prostate Gland Editorial Comment

Tags: 2009, Ellis R J, Journal of Urology, Urology & Nephrology

Four-year outcomes of hypofractionated high-dose-rate prostate brachytherapy and external beam radiotherapy

PURPOSE: High-dose-rate (HDR) brachytherapy boost in prostate cancer allows dose escalation and delivery of higher biologically effective dose (BED). We evaluated the outcomes of intensitymodulated radiation therapy (IMRT) and HDR boost in a…

Browse Items (7 total)